EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding

Elsa Wilma Böhm, Bernhard Stoffelns, Adrian Gericke iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054698 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Elsa Wilma Böhm und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany. Hauptthemen laut MEDLINE: Melanoma, Eye Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

β-adrenoreceptors (ARs) are members of the superfamily of G-protein-coupled receptors (GPCRs), and are activated by catecholamines, such as epinephrine and norepinephrine. Three subtypes of β-ARs (β1, β2, and β3) have been identified with different distributions among ocular tissues. Importantly, β-ARs are an established target in the treatment of glaucoma. Moreover, β-adrenergic signaling has been associated with the development and progression of various tumor types. Hence, β-ARs are a potential therapeutic target for ocular neoplasms, such as ocular hemangioma and uveal melanoma. This review aims to discuss the expression and function of individual β-AR subtypes in ocular structures, as well as their role in the treatment of ocular diseases, including ocular tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaEye DiseasesHumansReceptors, Adrenergic, betaNorepinephrineEpinephrineReceptors, Adrenergic, beta-2

Stichwörter der Autor:innen

catecholaminesglaucomaocular hemangiomauveal melanomaβ-adrenoreceptors

Substanzen

Receptors, Adrenergic, betaNorepinephrineEpinephrineReceptors, Adrenergic, beta-2

Autor:innen und Institutionen

  • Department of Ophthalmology, University Medical Center, Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55131 Mainz, Germany.

ORCID-Profile: Adrian Gericke

Zitieren

APA

Böhm, E. W., Stoffelns, B., & Gericke, A. (2023). β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054698

Vancouver

Böhm EW, Stoffelns B, Gericke A. β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054698

BibTeX
@article{Bhm2023,
  author = {Böhm, Elsa Wilma and Stoffelns, Bernhard and Gericke, Adrian},
  title = {β-Adrenoreceptors as Therapeutic Targets for Ocular Tumors and Other Eye Diseases—Historical Aspects and Nowadays Understanding},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054698}
}
Kostenlos starten →